Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can Kids' brains repair MS damage better? new study investigates

NCT ID NCT05258396

Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study uses advanced MRI scans to measure how well the brains of children with multiple sclerosis (MS) can repair myelin, the protective coating around nerve cells. Researchers will compare these repair levels with thinking and memory test scores. The goal is to understand if children truly have a greater ability to repair myelin than adults, which could guide future treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2022

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 18 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for patients : * age between 12 years old and 18 years old * RR-MS defined by 2017 McDonald criteria * no relapse the last 4 weeks * no methylprednisolone or prednisolone the last 4 weeks. * affiliated to the social security system * signature of the consent by the 2 holders of parental authority Inclusion Criteria for Volunteers: * age between 12 years old and 18 years old * absence of any neurological * signature of the consent by the 2 holders of parental authority Exclusion Criteria for both groups: * Parental rejection * Contre-indication of brain MRI: pace maker, tatoo of the face, claustrophobia…. * Pregnancy, copper intrauterine device

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Children with multiple sclerosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

multiple sclerosis pediatric multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Children with multiple sclerosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CIC Neurosciences - Pitié Salpêtrière

    RECRUITING

    Paris, 75013, France

  • Service de Neurologie Pédiatrique, Hôpital du Kremlin Bicêtre

    RECRUITING

    Le Kremlin-Bicêtre, 94270, France

  • Service de Neurologie, GH Pitié Salpêtrière

    NOT_YET_RECRUITING

    Paris, 75013, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.